In-vivo assessment of vascular injury for the prediction of in-stent restenosis

被引:3
|
作者
Cornelissen, Anne [1 ]
Florescu, Roberta Andreea [1 ]
Reese, Stefanie [2 ]
Behr, Marek [3 ]
Ranno, Anna [3 ]
Manjunatha, Kiran [2 ]
Schaaps, Nicole [1 ]
Boehm, Christian [4 ]
Liehn, Elisa Anamaria [5 ]
Zhao, Liguo [6 ]
Nilcham, Pakhwan [1 ]
Milzi, Andrea [1 ]
Schroeder, Jorg [1 ]
Vogt, Felix Jan [1 ]
机构
[1] Univ Hosp Aachen, Dept Cardiol Angiol & Internal Intens Med, Pauwelsstr 30, D-52074 Aachen, Germany
[2] Rhein Westfal TH Aachen, Inst Appl Mech, Mies Van der Rohe Str 1, D-52074 Aachen, Germany
[3] Rhein Westfal TH Aachen, Chair Computat Anal Tech Syst CATS, Ctr Simulat & Data Sci JARA CSD, D-52056 Aachen, Germany
[4] Rhein Westfal TH Aachen, AME Inst Appl Med Engn, Dept Biohybrid & Med Text BioTex, Helmholtz Inst, Aachen, Germany
[5] Univ Southern Denmark, Dept Mol Med, Cardiovasc & Renal Res Unit, Campusvej 55, DK-5230 Odense, Denmark
[6] Loughborough Univ, Sch Mech Elect & Mfg Engn, Loughborough LE11 3TU, Leics, England
关键词
Patient-individualized percutaneous coronary; intervention; Prediction; In stent restenosis; Stent malapposition; Optical coherence tomography; CORONARY-ARTERIES; UNDEREXPANSION; PIGS; DOGS;
D O I
10.1016/j.ijcard.2023.131151
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Despite optimizations of coronary stenting technology, a residual risk of in-stent restenosis (ISR) remains. Vessel wall injury has important impact on the development of ISR. While injury can be assessed in histology, there is no injury score available to be used in clinical practice.Methods: Seven rats underwent abdominal aorta stent implantation. At 4 weeks after implantation, animals were euthanized, and strut indentation, defined as the impression of the strut into the vessel wall, as well as neointimal growth were assessed. Established histological injury scores were assessed to confirm associations between indentation and vessel wall injury. In addition, stent strut indentation was assessed by optical coherence tomography (OCT) in an exemplary clinical case.Results: Stent strut indentation was associated with vessel wall injury in histology. Furthermore, indentation was positively correlated with neointimal thickness, both in the per-strut analysis (r = 0.5579) and in the per-section analysis (r = 0.8620; both p & LE; 0.001). In a clinical case, indentation quantification in OCT was feasible, enabling assessment of injury in vivo.Conclusion: Assessing stent strut indentation enables periprocedural assessment of stent-induced damage in vivo and therefore allows for optimization of stent implantation. The assessment of stent strut indentation might become a valuable tool in clinical practice.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Clinical outcomes for Sirolimus-Eluting stent implantation and vascular brachytherapy for the treatment of in-stent restenosis
    Saia, F
    Lemos, PA
    Hoye, A
    Sianos, G
    Arampatzis, CA
    de Feyter, PJ
    van der Giessen, WJ
    Smits, PC
    van Domburg, RT
    Serruys, PW
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2004, 62 (03) : 283 - 288
  • [42] Bioresorbable vascular scaffold to treat in-stent restenosis: Single-center experience
    Picard, Fabien
    Avram, Robert
    Marquis-Gravel, Guillaume
    Tadros, Victor-Xavier
    Ly, Hung Q.
    de Hemptinne, Quentin
    Dorval, Jean-Francois
    L'allier, Philippe L.
    Tanguay, Jean-Francois
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2017, 30 (06) : 558 - 563
  • [43] Prevalence, predictors, and outcomes of in-stent restenosis with calcified nodules
    Tada, Takeshi
    Miura, Katsuya
    Ikuta, Akihiro
    Ohya, Masanobu
    Shimada, Takenobu
    Osakada, Kohei
    Takamatsu, Makoto
    Taguchi, Yuya
    Kubo, Shunsuke
    Tanaka, Hiroyuki
    Fuku, Yasushi
    Kadota, Kazushige
    EUROINTERVENTION, 2022, 17 (16) : 1352 - +
  • [44] Highly calcific in-stent restenosis as a substrate for sirolimuseluting stent very late stent thrombosis
    De Maria, Giovanni Luigi
    Aurigemma, Cristina
    Niccoli, Giampaolo
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2015, 16 : S20 - S22
  • [45] In-Stent Restenosis in the Drug-Eluting Stent Era
    Dangas, George D.
    Claessen, Bimmer E.
    Caixeta, Adriano
    Sanidas, Elias A.
    Mintz, Gary S.
    Mehran, Roxana
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (23) : 1897 - 1907
  • [46] Waksman In-Stent Restenosis Classification: A Mechanism-Based Approach to the Treatment of Restenosis
    Shlofmitz, Evan
    Case, Brian C.
    Chen, Yuefeng
    Chezar-Azerrad, Chava
    Hashim, Hayder
    Garcia-Garcia, Hector M.
    Mintz, Gary S.
    Waksman, Ron
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2021, 33 : 62 - 67
  • [47] Bioresorbable scaffolds for the treatment of in-stent restenosis
    Oliver Dörr
    Christoph Liebetrau
    Jens Wiebe
    Franziska Hecker
    Johannes Rixe
    Helge Möllmann
    Christian Hamm
    Holger Nef
    Heart and Vessels, 2015, 30 : 265 - 269
  • [48] A novel mouse model of in-stent restenosis
    Rodriguez-Menocal, Luis
    Wei, Yuntao
    Pham, Si M.
    St-Pierre, Melissa
    Li, Sen
    Webster, Keith
    Goldschmidt-Clermont, Pascal
    Vazquez-Padron, Roberto I.
    ATHEROSCLEROSIS, 2010, 209 (02) : 359 - 366
  • [49] Association of ABO blood types with the risk of in-stent restenosis
    Pourafkari, L.
    Ghaffari, S.
    Ahmadi, M.
    Tajlil, A.
    Nader, N. D.
    PERFUSION-UK, 2015, 30 (06): : 507 - 513
  • [50] Stenting the stent: Alternative strategy for treating in-stent restenosis
    Cecena, FA
    CATHETERIZATION AND CARDIOVASCULAR DIAGNOSIS, 1996, 39 (04): : 377 - 382